Skip to main content

US Wrap: Growth products lead the pack

Nine deals were filed and launched in the US structured products market yesterday, with half the issuance made up by accelerated growth products. JP Morgan fed the confounding appetite for US equity exposure with a 300% leveraged participation rate in the S&P 500 in a one-year, principal-at-risk product with 33% capped return.

Barclays Bank and Eksportfinans were the only two issuers in the beleaguered reverse convertible space. Barclays is offering a six-month product linked to the equity of US homeware retail chain Bed Bath and Beyond, with an 11% annualised coupon paid monthly, and a 65% barrier before investors are repaid in shares. Eksporfinans's product also has a six-month maturity and will be sold by Wachovia

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

Show password
Hide password

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here